Genetic inactivation or antibody‐mediated inhibition of endosialin resulted in reduced primary tumor growth and metastasis in mouse models of colon cancer, melanoma, and breast cancer (Nanda et al, 2006; Rybinski et al, 2015; Viski et al, 2016). Here, CD248 is linked to neoplasm.